Scrivo R, Conigliaro P, Riccieri V, Di Franco M, Alessandri C, Spadaro A, Perricone R, Valesini G
Dipartimento di Medicina Interna e Specialità Mediche, Reumatologia, Sapienza Università di Roma, Roma, Italy.
Clin Exp Immunol. 2015 Feb;179(2):300-8. doi: 10.1111/cei.12449.
Evidence exists that interleukin (IL)-10 family cytokines may be involved in the pathogenesis of rheumatoid arthritis (RA). We sought to determine whether or not these cytokines are involved in psoriatic arthritis (PsA). We conducted a prospective study on patients with PsA, RA and osteoarthritis (OA); healthy controls (HC) were also included. We analysed IL-20, IL-24 and IL-19 serum and synovial fluid (SF) levels and change of serum levels following treatment with biological agents. IL-20 serum levels were increased in PsA and RA compared with OA patients and HC and with matched SF levels. IL-24 serum levels in PsA, RA and OA patients were higher than those in HC and also with respect to matched SF in PsA. IL-19 serum levels were higher in HC and OA compared with PsA and RA patients; IL-19 SF levels were higher in PsA and RA compared with OA patients, and in PsA compared with RA patients. PsA and RA patients showed a reduction of IL-19 serum levels after biological treatment. Therefore, IL-19 seems to be involved mainly in the joint inflammation, whereas IL-20 and IL-24 appear to participate mainly in the systemic responses. These findings may further the comprehension of the contribution of these cytokines to the inflammatory response involved in chronic arthritis, as well as to the development of novel therapeutic strategies.
有证据表明白细胞介素(IL)-10家族细胞因子可能参与类风湿关节炎(RA)的发病机制。我们试图确定这些细胞因子是否参与银屑病关节炎(PsA)。我们对PsA、RA和骨关节炎(OA)患者进行了一项前瞻性研究;也纳入了健康对照(HC)。我们分析了IL-20、IL-24和IL-19的血清和滑液(SF)水平以及生物制剂治疗后血清水平的变化。与OA患者和HC相比,PsA和RA患者的IL-20血清水平升高,且与匹配的SF水平相关。PsA、RA和OA患者的IL-24血清水平高于HC,且与PsA中匹配的SF水平相关。与PsA和RA患者相比,HC和OA患者的IL-19血清水平更高;与OA患者相比,PsA和RA患者的IL-19 SF水平更高,且与RA患者相比,PsA患者的IL-19 SF水平更高。生物治疗后,PsA和RA患者的IL-19血清水平降低。因此,IL-19似乎主要参与关节炎症,而IL-20和IL-24似乎主要参与全身反应。这些发现可能会进一步加深对这些细胞因子在慢性关节炎炎症反应中的作用的理解,以及对新型治疗策略的开发。